Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of angiotensin-converting enzyme 2, transmembrane serine protease 2, and sirtuin 1 proteins in lungs of different age groups.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026
Same author

Mast cells release DNA Extracellular Traps (DETs) in response to SARS-CoV-2 and its spike protein.

Cell communication and signaling : CCS·2026
Same author

Implementation of an interdisciplinary research model at a tertiary University Hospital in São Paulo, Brazil: post-COVID-19 cohort study.

Clinics (Sao Paulo, Brazil)·2026
Same author

Correction: Does the use of continuous positive airway pressure devices pose a risk of microplastic exposure to the upper airway? A pilot study.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Curbing health harms from microplastics.

BMJ (Clinical research ed.)·2026
Same author

Pulmonary Complications in Fatal Yellow Fever, Brazil, 2017-2019.

Emerging infectious diseases·2026

Related Experiment Videos

Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.

Thais Mauad1, Marisa Dolhnikoff

  • 1Department of Pathology, Sao Paulo University Medical School, Sao Paulo, Brazil. tmauad@usp.br

Current Opinion in Pulmonary Medicine
|November 29, 2007
PubMed
Summary

Asthma and chronic obstructive pulmonary disease (COPD) share overlapping pathological features, including airway inflammation and structural changes. Understanding these similarities and differences is key to improving diagnosis and treatment for patients with these respiratory conditions.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Pathology
  • Immunology

Background:

  • Asthma and COPD are distinct diseases with unique clinical, physiological, and pathological characteristics.
  • However, overlapping symptoms and physiological abnormalities are common, complicating diagnosis and management.
  • Severe asthma can present with fixed airway obstruction, while COPD may exhibit hyperresponsiveness and eosinophilia.

Purpose of the Study:

  • To review the pathological similarities and differences between asthma and COPD.
  • To understand how pathological overlaps contribute to overlapping clinical and physiological phenotypes.
  • To inform better treatment and long-term management strategies for patients with these conditions.

Main Methods:

  • Review of existing literature on the pathology of asthma and COPD.
  • Analysis of inflammatory and structural changes in both diseases.
  • Comparison of airway compartments and cellular infiltrates.

Main Results:

  • Inflammatory overlaps include neutrophilia in severe asthma and CD8+ T cell association with lung function decline in COPD.
  • Minimizing eosinophilia in COPD may reduce exacerbations.
  • Structural changes like epithelial alterations, extracellular matrix deposition, and mucus gland hypertrophy occur in both; however, asthma features a thicker reticular basement membrane and smooth muscle abnormalities, while emphysema is characteristic of COPD.

Conclusions:

  • Recognizing pathological similarities and differences is crucial for understanding overlapping phenotypes.
  • This understanding can lead to more tailored and effective treatment plans.
  • Improved management strategies can be developed by appreciating the distinct and shared pathological features of asthma and COPD.